T-cell Receptor Gene Usage in Colorectal Tumors
Author Information
Author(s): B. Ostenstad, M. Sioud, T. Lea, E. Schlichting, M. Harboe
Primary Institution: Institute of Immunology and Rheumatology, National Hospital, Oslo, Norway
Hypothesis
Is there a limited heterogeneity in T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumors?
Conclusion
The study found limited heterogeneity in the V-gene usage of TILs from colorectal cancer patients, suggesting a local antigen-driven immune response.
Supporting Evidence
- TILs showed a marked restriction in V-gene usage compared to PBLs.
- Three out of seven patients exhibited an oligoclonal pattern in their TIL V-gene usage.
- The study supports the hypothesis of a specific immune response against malignant tumors.
Takeaway
The study looked at immune cells in colorectal tumors and found that they mostly use a few specific genes, which means they might be responding to the cancer.
Methodology
The study used PCR technology to analyze T-cell receptor V-gene usage in tumor-infiltrating lymphocytes from colorectal cancer patients.
Limitations
The PCR method is semiquantitative, making comparisons between samples difficult.
Participant Demographics
Patients with primary adenocarcinoma of the colon or rectum.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website